MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells

Journal of Biological Chemistry

Volumn 288, Issue 43, 2013, Pages 30892-30903

  Alam, Maroof ^a   Ahmad, Rehan ^a,b   Rajabi, Hasan ^a   Kharbanda, Akriti ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; BREAST CANCER CELLS; ONCOPROTEINS; OVER-EXPRESSION;

ALDEHYDES;

CELLS;

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; CCAAT ENHANCER BINDING PROTEIN DELTA; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN 1 C; ONCOPROTEIN; UNCLASSIFIED DRUG;

ALDH1A1 GENE; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STEM CELL EXPANSION;

ALDH1; BREAST CANCER; C/EBP TRANSCRIPTION FACTOR; CANCER; ERK; MUC1;

ALDEHYDE DEHYDROGENASE; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MUCIN-1; NEOPLASM PROTEINS; PROTEIN SUBUNITS; TRANSCRIPTION, GENETIC;

EID: 84886695948     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.477158     Document Type: Article

References (60)

1. Ramji, D. P., and Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575
2. Eaton, E. M., Hanlon, M., Bundy, L., and Sealy, L. (2001) Characterization of C/EBPα isoforms in normal versus neoplastic mammary epithelial cells. J. Cell. Physiol. 189, 91-105
3. Descombes, P., and Schibler, U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.. Cell 67, 569-579
4. Grimm, S. L., and Rosen, J. M. (2003) The role of C/EBPbeta in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 191-204
5. La Marca, H. L., Visbal, A. P., Creighton, C. J., Liu, H., Zhang, Y., Behbod, F., and Rosen, J. M. (2010) CCAAT/enhancer-binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.. Stem Cells 28, 535-544
6. Bundy, L. M., and Sealy, L. (2003) CCAAT/enhancer binding protein beta (C/EBPα)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.. Oncogene 22, 869-883
7. Atwood, A. A., Jerrell, R., and Sealy, L. (2011) Negative regulation of C/EBPα1 by sumoylation in breast cancer cells. PLoS One 6, e25205
8. Zahnow, C. A., Younes, P., Laucirica, R., and Rosen, J. M. (1997) Overexpression of C/EBPα-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.. J. Natl. Cancer Inst. 89, 1887-1891
9. Gomis, R. R., Alarcón, C., Nadal, C., Van Poznak, C., and Massagué, J. (2006) C/EBPα at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.. Cancer Cell 10, 203-214
10. Kowenz-Leutz, E., Twamley, G., Ansieau, S., and Leutz, A. (1994) Novel mechanism of C/EBPα (NF-M) transcriptional control: activation through derepression. Genes Dev. 8, 2781-2791
11. Williams, S. C., Baer, M., Dillner, A. J., and Johnson, P. F. (1995) CRP2 (C/EBPα) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity.. EMBO J. 14, 3170-3183
12. Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., and Akira, S. (1993) Phosphorylation at threonine 235 by a RAS-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL Proc. Natl. Acad. Sci. U. S. A. 90, 2207-2211
13. Marchitti, S. A., Brocker, C., Stagos, D., and Vasiliou, V. (2008) Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 4, 697-720
14. Ma, I., and Allan, A. L. (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 7, 292-306
15. Douville, J., Beaulieu, R., and Balicki, D. (2009) ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev. 18, 17-25
16. Chute, J. P., Muramoto, G. G., Whitesides, J., Colvin, M., Safi, R., Chao, N. J., and McDonnell, D. P. (2006) Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.. Proc. Natl. Acad. Sci. U. S. A. 103, 11707-11712
17. Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M. S., and Dontu, G. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.. Cell Stem Cell 1, 555-567
18. Ginestier, C., Wicinski, J., Cervera, N., Monville, F., Finetti, P., Bertucci, F., Wicha, M. S., Birnbaum, D., and Charafe-Jauffret, E. (2009) Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8, 3297-3302
19. Yanagawa, Y., Chen, J. C., Hsu, L. C., and Yoshida, A. (1995) The transcriptional regulation of human aldehyde dehydrogenase I gene. The structural and functional analysis of the promoter. J. Biol. Chem. 270, 17521-17527
20. Elizondo, G., Corchero, J., Sterneck, E., and Gonzalez, F. J. (2000) Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancerbinding protein beta.. J. Biol. Chem. 275, 39747-39753
21. Kufe, D. (2009) Mucins in cancer: function, prognosis and therapy. Nature Reviews Cancer 9, 874-885
22. Kufe, D. (2013) MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.. Oncogene 32, 1073-1081
23. Li, Y., Ren, J., Yu, W., Li, Q., Kuwahara, H., Yin, L., Carraway, K. L., 3rd, and Kufe, D. (2001) The EGF receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and catenin.. J. Biol. Chem. 276, 35239-35242
24. Li, Y., Yu, W.-H., Ren, J., Chen, W., Huang, L., Kharbanda, S., Loda, M., and Kufe, D. (2003) Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 protein. Mol. Cancer Res. 1, 765-775
25. Ramasamy, S., Duraisamy, S., Barbashov, S., Kawano, T., Kharbanda, S., and Kufe, D. (2007) The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol. Cell 27, 992-1004
26. Raina, D., Uchida, Y., Kharbanda, A., Rajabi, H., Panchamoorthy, G., Jin, C., Kharbanda, S., Scaltriti, M., Baselga, J., and Kufe, D. (2013) Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells Oncogene, in press
27. Raina, D., Kharbanda, S., and Kufe, D. (2004) The MUC1 oncoprotein activates the anti-apoptotic PI3K/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts.. J. Biol. Chem. 279, 20607-20612
28. Raina, D., Kosugi, M., Ahmad, R., Panchamoorthy, G., Rajabi, H., Alam, M., Shimamura, T., Shapiro, G., Supko, J., Kharbanda, S., and Kufe, D. (2011) Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol. Cancer Therapeutics 10, 806-816
29. Pandey, P., Kharbanda, S., and Kufe, D. (1995) Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res. 55, 4000-4003
30. Ahmad, R., Raina, D., Joshi, M. D., Kawano, T., Ren, J., Kharbanda, S., and Kufe, D. (2009) MUC1-C oncoprotein functions as a direct activator of the NF-κB p65 transcription factor. Cancer Res. 69, 7013-7021
31. Ahmad, R., Rajabi, H., Kosugi, M., Joshi, M., Alam, M., Vasir, B., Kawano, T., Kharbanda, S., and Kufe, D. (2011) MUC1-C oncoprotein promotes STAT3 activation in an auto-inductive regulatory loop. Science Signaling 4, ra9
32. Rajabi, H., Ahmad, R., Jin, C., Joshi, M., Guha, M., Alam, M., Kharbanda, S., and Kufe, D. (2012) MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells. Prostate 72, 1659-1668
33. Jin, C., Rajabi, H., Pitroda, S., Kharbanda, A., Li, A., Weichselbaum, R., and Kufe, D. (2012) Cooperative interaction between the MUC1 oncoprotein and the Rab31 GTPase in human breast cancer cells.. PLoS One 7, e39432
34. Raina D, Ahmad R, Rajabi H, Panchamoorthy G, Kharbanda S, and Kufe, D. (2012) Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells. Int. J. Oncol 40, 1643-1649
35. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., and Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632
36. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., and Gerritsen, M. E. (1997) Novel inhibitors of cytokine-induced IκBκ phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.. J. Biol. Chem. 272, 21096-21103
37. Leng, Y., Cao, C., Ren, J., Huang, L., Chen, D., Ito, M., and Kufe, D. (2007) Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup J. Biol. Chem. 282, 19321-19330
38. Panchamoorthy, G., Rehan, H., Kharbanda, A., Ahmad, R., and Kufe, D. (2011) Amonoclonal antibody against the oncogenic mucin 1 cytoplasmic domain. Hybridoma 30, 531-535
39. Rajabi H, Joshi, M. D., Jin, C., Ahmad, R., and Kufe, D. (2011) Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells. Prostate 71, 1299-1308
40. Wang, Q., Carroll, J. S., and Brown, M. (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.. Mol. Cell 19, 631-642
41. Lee, S., Shuman, J. D., Guszczynski, T., Sakchaisri, K., Sebastian, T., Copeland, T. D., Miller, M., Cohen, M. S., Taunton, J., Smart, R. C., Xiao, Z., Yu, L. R., Veenstra, T. D., and Johnson, P. F. (2010) RSK-mediated phosphorylation in the C/EBP{α} leucine zipper regulates DNA binding, dimerization, and growth arrest activity.. Mol. Cell. Biol. 30, 2621-2635
42. Hattrup, C. L., and Gendler, S. J. (2006) MUC1alters oncogenic events and transcription in human breast cancer cells. Breast Cancer Res. 8, R37
43. Yao, M., Zhang, W., Zhang, Q., Xing, L., Xu, A., Liu, Q., and Cui, B. (2011) Overexpression of MUC1 enhances proangiogenic activity of non-smallcell lung cancer cells through activation of Akt and extracellular signalregulated kinase pathways.. Lung 189, 453-460
44. Niehof, M., Kubicka, S., Zender, L., Manns, M. P., and Trautwein, C. (2001) Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBPα) transcription.. J. Mol. Biol. 309, 855-868
45. Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M. J., Gillet, P., Merville, M. P., Bours, V., and Malaise, M. G. (2004) 15-deoxy-Δ12, 14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts.. J. Biol. Chem. 279, 22399-22403
46. Stein, B., Cogswell, P. C., and Baldwin, A. S., Jr. (1993) Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.. Mol. Cell. Biol. 13, 3964-3974
47. Piwien-Pilipuk, G., MacDougald, O., and Schwartz, J. (2002) Dual regulation of phosphorylation and dephosphorylation of C/EBPα modulate its transcriptional activation and DNA binding in response to growth hormone.. J. Biol. Chem. 277, 44557-44565
48. Robinson, G. W., Johnson, P. F., Hennighausen, L., and Sterneck, E. (1998) The C/EBPα transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland.. Genes Dev. 12, 1907-1916
49. Seagroves, T. N., Krnacik, S., Raught, B., Gay, J., Burgess-Beusse, B., Darlington, G. J., and Rosen, J. M. (1998) C/EBPα, but not C/EBPκ, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland.. Genes Dev. 12, 1917-1928
50. Rajabi, H., Ahmad, R., Jin, C., Kosugi, M., Alam, M., Joshi, M., and Kufe, D. (2012) MUC1-C oncoprotein induces TCF7L2 activation and promotes cyclin D1 expression in human breast cancer cells.. J. Biol. Chem. 287, 10703-10713
51. Su, W. C., Chou, H. Y., Chang, C. J., Lee, Y. M., Chen, W. H., Huang, K. H., Lee, M. Y., and Lee, S. C. (2003) Differential activation of a C/EBPα isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene.. J. Biol. Chem. 278, 51150-51158
52. Rosen, J. M., Wyszomierski, S. L., and Hadsell, D. (1999) Regulation of milk protein gene expression. Annu. Rev. Nutr. 19, 407-436
53. Trasino, S. E., Harrison, E. H., and Wang, T. T. (2007) Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP.. Exp. Biol. Med. 232, 762-771
54. Marcato, P., Dean, C. A., Pan, D., Araslanova, R., Gillis, M., Joshi, M., Helyer, L., Pan, L., Leidal, A., Gujar, S., Giacomantonio, C. A., and Lee, P. W. (2011) Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.. Stem Cells 29, 32-45
55. Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M. H., Diebel, M. E., Monville, F., Dutcher, J., Brown, M., Viens, P., Xerri, L., Bertucci, F., Stassi, G., Dontu, G., Birnbaum, D., and Wicha, M. S. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.. Cancer Res. 69, 1302-1313
56. Christgen, M., Ballmaier, M., Bruchhardt, H., Von Wasielewski, R., Kreipe, H., and Lehmann, U. (2007) Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.. Mol. Cell Biochem. 306, 201-212
57. Engelmann, K., Shen, H., and Finn, O. J. (2008) MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC Cancer Res. 68, 2419-2426
58. Rajabi, H., Alam, M., Takahashi, H., Kharbanda, A., Guha, M., Ahmad, R., and Kufe, D. (2013) MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.. Oncogene, in press
59. Park, S. Y., Lee, H. E., Li, H., Shipitsin, M., Gelman, R., and Polyak, K. (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.. Clin. Cancer Res. 16, 876-887
60. Siroy, A., Abdul-Karim, F. W., Miedler, J., Fong, N., Fu, P., Gilmore, H., and Baar, J. (2013) MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer. Hum. Pathol. 44, 2159-2166